After nearly ten years in the Healthcare Intelligence Business, BioWisdom knows that it’s not just about the data – its about the metadata! Metadata brings data to life, it provides context, it transforms, translates and makes relevant those noisy, digital tomes. Intelligent Metadata helps to maximise the value of your content whether it’s brand new or ancient history. That legacy of expertise, observation, labour and investment. Let BioWisdom help you find it, release it, profit from it!
Latest News
BioWisdom SRS Adds Support for Chemistry Integration
BioWisdom is proud to announce the recent addition of support for chemistry searches and integration into the standard edition of our data search and retrieval platform, BioWisdom SRS.
This latest addition allows users unprecedented levels of integration of chemistry data with the wide range of public and proprietary datasets available within SRS. Starting from a structure [...]
Metawise
Metawise is a unique and powerful ontology that can identify, translate and connect medically relevant relationships expressed in scientific content. The online Conceptualiser demonstration uses Metawise as part of an online service to annotate and harmonize data. Access to the demo is restricted to registered users of this website.
Old Data, New Insight
19TH January 2010 Cambridge, UK – BioWisdom. a provider of specialist medical metadata and Intelligence Solutions for Healthcare, is pleased to announce the publication of an exciting new paper in Chem. Res. Toxicol. Using metadata derived from BioWisdom’s Safety Intelligence Program, Alex Tropsha and colleagues at the University of North Carolina have applied QSAR modelling [...]
BioWisdom Announces Release of Safety Intelligence Program Version 3.0
BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today announced that it has released of Version 3 of its award-winning Safety Intelligence Program.
The Safety Intelligence Program is a unique system in providing comprehensive intelligence around compounds causing adverse effects in tissues, and enables in-depth understanding of mechanistic relationships drug-induced [...]
BioWisdom’s Safety Intelligence Program Win’s ‘Best Practice’ Award for Astrazeneca
20 May 2009, Cambridge, UK – BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today announces that its Safety Intelligence Program has been awarded a prestigious “Best Practices” award at the recent Bio-IT World Life Sciences Conference and Expo in Boston.
This award recognises the implementation of the Safety Intelligence [...]